NL
DE
At the 10th European Elastin Meeting held in Nijmegen in June this year, Lars Damen, theme Reconstructive and regenerative medicine, received the early-stage researcher award for his poster entitled “Development of tools to study the sulfation pattern of heparan sulfate involved in elastic fiber biology”.
The poster focused on the development of single chain variable fragment antibodies to target several sulfation patterns in the glycosaminoglycan heparan sulfate. These antibodies can be applied to study the interaction of heparan sulfate in (patho-)physiological processes, including elastic fiber biology.
Lars Damen
10th European Elastin Meeting
Related news items
Willeke Daamen ratified as ETRS board member
3 November 2021 Willeke Daamen, theme Reconstructive and regenerative medicine appointed as board member of The European Tissue Repair Society (ETRS). read more
Grant for early detection of ovarian cancer
5 June 2020 The Department of Biochemistry (Toin van Kuppevelt/Willeke Daamen), together with the Department of Gynecology, has been awarded a grant of 144 kEuro for the development of an assay for the early detection of ovarian cancer. read more
3 million euro for Marie Curie ITN SkinTERM
5 June 2020 The European Union has provisionally awarded a grant of more than 3 million euro to the SkinTERM project “Skin Tissue Engineering and Regenerative Medicine: From skin repair to regeneration”. SkinTERM is coordinated with Willeke Daamen as coordinator and Toin van Kuppevelt as vice coordinator. read moreFET-OPEN grant for Toin van Kuppevelt and Willeke Daamen
6 March 2020 A grant of 592 kEuro has been awarded to Toin van Kuppevelt and Willeke Daamen, theme Reconstructive and regenerative medicine, for a Horizon 2020 FET-OPEN project entitled “Heparin and heparan sulphate: from sequence determination to therapeutic strategies for Parkinson’s disease”. read more
Plugging the gap ZonMw/Health Holland grant
3 March 2020 RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM). read more
